Understanding the natural variability of prion diseases

Vaccine

Volumn 25, Issue 30 SPEC. ISS., 2007, Pages 5631-5636

  Geissen, Markus ^a   Krasemann, Susanne ^a   Matschke, Jakob ^a   Glatzel, Markus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

CJD; Neurodegeneration; Prions

Indexed keywords

CELL PROTEIN; PRION PROTEIN;

ARTICLE; CENTRAL NERVOUS SYSTEM; CHEMICAL ANALYSIS; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; GENETIC PROCEDURES; HISTOLOGY; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRION; PRION DISEASE; PRIORITY JOURNAL;

EID: 34447092796     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.041     Document Type: Article

References (57)

1. Collins P.S., Lawson V.A., and Masters P.C. Transmissible spongiform encephalopathies. Lancet 363 9402 (2004) 51-61
2. Ladogana A., Puopolo M., Croes E.A., Budka H., Jarius C., Collins S., et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 64 9 (2005) 1586-1591
3. Buschmann A., Gretzschel A., Biacabe A.G., Schiebel K., Corona C., Hoffmann C., et al. Atypical BSE in Germany-Proof of transmissibility and biochemical characterization. Vet Microbiol (2006)
4. Harder A., Jendroska K., Kreuz F., Wirth T., Schafranka C., Karnatz N., et al. Novel twelve-generation kindred of fatal familial insomnia from germany representing the entire spectrum of disease expression. Am J Med Genet 87 4 (1999) 311-316
5. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 9006 (1996) 921-925
6. Hill A.F., Desbruslais M., Joiner S., Sidle K.C., Gowland I., Collinge J., et al. The same prion strain causes vCJD and BSE [letter]. Nature 389 6650 (1997) 448-450
7. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389 6650 (1997) 498-501
8. Aguzzi A., and Weissmann C. Spongiform encephalopathies: a suspicious signature. Nature 383 6602 (1996) 666-667
9. Aguzzi A. Between cows and monkeys. Nature 381 6585 (1996) 734
10. Brown P., Preece M., Brandel J.P., Sato T., McShane L., Zerr I., et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55 8 (2000) 1075-1081
11. Caughey B., and Baron G.S. Prions and their partners in crime. Nature 443 7113 (2006) 803-810
12. Masters C.L., Harris J.O., Gajdusek D.C., Gibbs Jr. C.J., Bernoulli C., and Asher D.M. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5 2 (1979) 177-188
13. Zerr I., Pocchiari M., Collins S., Brandel J.P., de Pedro Cuesta J., Knight R.S., et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55 6 (2000) 811-815
14. Otto M., Wiltfang J., Tumani H., Zerr I., Lantsch M., Kornhuber J., et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225 3 (1997) 210-212
15. Sanchez-Juan P., Green A., Ladogana A., Cuadrado-Corrales N., Saanchez-Valle R., Mitrovaa E., et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67 4 (2006) 637-643
16. Tribl G.G., Strasser G., Zeitlhofer J., Asenbaum S., Jarius C., Wessely P., et al. Sequential MRI in a case of Creutzfeldt-Jakob disease. Neuroradiology 44 3 (2002) 223-226
17. Linguraru M.G., Ayache N., Bardinet E., Ballester M.A., Galanaud D., Haik S., et al. Differentiation of sCJD and vCJD forms by automated analysis of basal ganglia intensity distribution in multisequence MRI of the brain-definition and evaluation of new MRI-based ratios. IEEE Trans Med Imaging 25 8 (2006) 1052-1067
18. Russmann H., Vingerhoets F., Miklossy J., Maeder P., Glatzel M., Aguzzi A., et al. Sporadic Creutzfeldt-Jakob disease A comparison of pathological findings and diffusion weighted imaging. J Neurol 252 3 (2005) 338-342
19. Windl O., Dempster M., Estibeiro J.P., Lathe R., Desilva R., Esmonde T., et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom-a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98 3 (1996) 259-264
20. Gabizon R., Rosenmann H., Meiner Z., Kahana I., Kahana E., Shugart Y., et al. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). Am J Hum Genet 53 4 (1993) 828-835
21. Goldfarb L.G., Korczyn A.D., Brown P., Chapman J., and Gajdusek D.C. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin [letter]. Lancet 336 8715 (1990) 637-638
22. Goldfarb L.G., Mitrova E., Brown P., Toh B.K., and Gajdusek D.C. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia [letter]. Lancet 336 8713 (1990) 514-515
23. Kovacs G.G., Puopolo M., Ladogana A., Pocchiari M., Budka H., van Duijn C., et al. Genetic prion disease: the EUROCJD experience. Hum Genet 118 2 (2005) 166-174
24. Collinge J., Brown J., Hardy J., Mullan M., Rossor M.N., Baker H., et al. Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 115 Pt. 3 (1992) 687-710
25. Kitamoto T., Iizuka R., and Tateishi J. An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192 2 (1993) 525-531
26. Hsiao K., Baker H.F., Crow T.J., Poulter M., Owen F., Terwilliger J.D., et al. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338 6213 (1989) 342-345
27. Itoh Y., Yamada M., Hayakawa M., Shozawa T., Tanaka J., Matsushita M., et al. A variant of Gerstmann-Straussler-Scheinker disease carrying codon 105 mutation with codon 129 polymorphism of the prion protein gene: a clinicopathological study. J Neurol Sci 127 1 (1994) 77-86
28. Ghetti B., Dlouhy S.R., Giaccone G., Bugiani O., Frangione B., Farlow M.R., et al. Gerstmann-Straussler-Scheinker disease and the Indiana kindred. Brain Pathol 5 1 (1995) 61-75
29. Hsiao K., Dlouhy S.R., Farlow M.R., Cass C., Da Costa M., Conneally P.M., et al. Mutant prion proteins in Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles. Nat Genet 1 1 (1992) 68-71
30. Gambetti P., Parchi P., Petersen R.B., Chen S.G., and Lugaresi E. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 5 1 (1995) 43-51
31. Goldfarb L.G., Petersen R.B., Tabaton M., Brown P., LeBlanc A.C., Montagna P., et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258 5083 (1992) 806-808
32. Alperovitch A., Zerr I., Pocchiari M., Mitrova E., de Pedro Cuesta J., Hegyi I., et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease [letter]. Lancet 353 9165 (1999) 1673-1674
33. Glatzel M., Abela E., Maissen M., and Aguzzi A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349 19 (2003) 1812-1820
34. Polymenidou M., Stoeck K., Glatzel M., Vey M., Bellon A., and Aguzzi A. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 4 12 (2005) 805-814
35. Peden A.H., Ritchie D.L., Head M.W., and Ironside J.W. Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt-Jakob disease. Am J Pathol 168 3 (2006) 927-935
36. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez Garcia F., et al. NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97 1 (2000) 145-150
37. Abid K., and Soto C. The intriguing prion disorders. Cell Mol Life Sci 63 19-20 (2006) 2342-2351
38. Ironside J.W., Ritchie D.L., and Head M.W. Phenotypic variability in human prion diseases. Neuropathol Appl Neurobiol 31 6 (2005) 565-579
39. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA (1993)
40. Schoch G., Seeger H., Bogousslavsky J., Tolnay M., Janzer R.C., Aguzzi A., et al. Analysis of prion strains by PrP(Sc) profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 3 2 (2005) e14
41. Watts J.C., Balachandran A., and Westaway D. The expanding universe of prion diseases. PLoS Pathog 2 3 (2006) e26
42. Notari S., Capellari S., Giese A., Westner I., Baruzzi A., Ghetti B., et al. Effects of different experimental conditions on the PrPSc core generated by protease digestion: Implications for strain typing and molecular classification of CJD. J Biol Chem (2004)
43. Hill A.F., Joiner S., Wadsworth J.D., Sidle K.C., Bell J.E., Budka H., et al. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126 Pt. 6 (2003) 1333-1346
44. Parchi P., Giese A., Capellari S., Brown P., Schulz-Schaeffer W., Windl O., et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46 2 (1999) 224-233
45. Cali I., Castellani R., Yuan J., Al-Shekhlee A., Cohen M.L., Xiao X., et al. Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain 129 Pt. 9 (2006) 2266-2277
46. Wadsworth J.D.F., Joiner S., Hill A.F., Campbell T.A., Desbruslais M., Luthert P.J., et al. Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay. Lancet 358 (2001) 171-180
47. Safar J.G., Geschwind M.D., Deering C., Didorenko S., Sattavat M., Sanchez H., et al. Diagnosis of human prion disease. Proc Natl Acad Sci USA 102 9 (2005) 3501-3506
48. Lourenco P.C., Schmerr M.J., MacGregor I., Will R.G., Ironside J.W., and Head M.W. Application of an immunocapillary electrophoresis assay to the detection of abnormal prion protein in brain, spleen and blood specimens from patients with variant Creutzfeldt-Jakob disease. J Gen Virol 87 Pt. 10 (2006) 3119-3124
49. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., et al. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4 10 (1998) 1157-1165
50. Castilla J., Saa P., Hetz C., and Soto C. In vitro generation of infectious scrapie prions. Cell 121 2 (2005) 195-206
51. Castilla J., Saa P., Morales R., Abid K., Maundrell K., and Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Meth Enzymol 412 (2006) 3-21
52. Saa P., Castilla J., and Soto C. Presymptomatic detection of prions in blood. Science 313 5783 (2006) 92-94
53. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., et al. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol 5 4 (1995) 459-466
54. Budka H. Neuropathology of prion diseases. Br Med Bull 66 (2003) 121-130
55. Legname G., Baskakov I.V., Nguyen H.O., Riesner D., Cohen F.E., DeArmond S.J., et al. Synthetic mammalian prions. Science 305 5684 (2004) 673-676
56. Aguzzi A., Heppner F.L., Heikenwalder M., Prinz M., Mertz K., Seeger H., et al. Immune system and peripheral nerves in propagation of prions to CNS. Br Med Bull 66 (2003) 141-159
57. Glatzel M., Stoeck K., Seeger H., Luhrs T., and Aguzzi A. Human prion diseases: molecular and clinical aspects. Arch Neurol 62 4 (2005) 545-552